Brief: MyMD Pharmaceuticals Receives FDA Ind Clearance To Begin Phase 2 Trial Of MYMD-1
16/11/2021 14:28
Nov 16 (Reuters) - MyMD Pharmaceuticals Inc MYMD.O :
* MYMD PHARMACEUTICALS RECEIVES FDA IND CLEARANCE TO BEGIN
PHASE 2
TRIAL OF MYMD-1 FOR EXTENDING HEALTHY LIFESPAN
* MYMD PHARMACEUTICALS INC - PHASE 2 TRIAL RECRUITING BEGINS
IMMEDIATELY; EFFICACY DATA EXPECTED BY END OF Q1 OF 2022
Source text for Eikon: ID:nBw1wxz86a
Further company coverage: MYMD.O
((Reuters.Briefs@thomsonreuters.com;))